+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07881159

Long-Term Observational Study and Registry for People with Noonan Syndrome in Italy

Led by Istituto Giannina Gaslini · Updated on 2026-10-19

400

Participants Needed

35

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are creating a national registry in Italy for people with Noonan syndrome, a rare genetic condition that can affect growth, the heart, and other parts of the body. Because this condition is uncommon, doctors have limited information about its progression. This study aims to gather detailed data on signs, symptoms, gene changes, growth patterns, health problems, and the effects of growth hormone treatment over time. Doctors at participating centers will securely enter health information of individuals with genetically confirmed Noonan syndrome into an online platform. This includes personal details, medical history, genetic test results, treatments, and heart check results, with follow-up heart evaluations approximately every two years. The registry will include both existing patients and newly diagnosed individuals, with updates over time. Participants will be monitored through their ongoing medical care, with data collected on their health status and treatments. The study will last five years and aims to establish a comprehensive database to help guide long-term care recommendations and support future clinical trials. Participation is voluntary, and no new treatments are tested in this study.

CONDITIONS

Brief Title

Registro Nazionale Sindrome Noonan / National Registry of Noonan Syndrome

Research Team

M

Mohamad Maghnie, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here